Player FM uygulamasıyla çevrimdışı Player FM !
Alzheimer's drug approvals & possible impact for patients
Manage episode 429832001 series 3336151
The FDA has approved a second Alzheimer’s drug that can slow the onset of the disease and it is expected that the drug will be approved for use in the EU in the coming months. To the possible impact this could have Luke O'Neill is joined by Prof Sean Kennelly, Clinical Director of the Institute of Memory and Cognition in Tallaght University Hospital & Newstalk presenter, Clare McKenna.
1058 bölüm
Manage episode 429832001 series 3336151
The FDA has approved a second Alzheimer’s drug that can slow the onset of the disease and it is expected that the drug will be approved for use in the EU in the coming months. To the possible impact this could have Luke O'Neill is joined by Prof Sean Kennelly, Clinical Director of the Institute of Memory and Cognition in Tallaght University Hospital & Newstalk presenter, Clare McKenna.
1058 bölüm
すべてのエピソード
×Player FM'e Hoş Geldiniz!
Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.